Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study

NCT02448342 is registered in ClinicalTrials.gov with Sensible Medical Innovations Ltd. as lead sponsor.

NCT NCT02448342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02448342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Lead sponsor
Sensible Medical Innovations Ltd.
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2015
Completion date
November 30, 2017
Enrollment
380 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure